HZNP has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Horizon Pharma PLC's account receivable for the three months ended in Dec. 2015 was $210.4 Mil. Horizon Pharma PLC's revenue for the three months ended in Dec. 2015 was $244.5 Mil. Hence, Horizon Pharma PLC's days sales outstanding for the three months ended in Dec. 2015 was 78.53.
During the past 8 years, Horizon Pharma PLC's highest Days Sales Outstanding was 124.99. The lowest was 67.08. And the median was 89.59.
Horizon Pharma PLC's days sales outstanding increased from Dec. 2014 (64.95) to Dec. 2015 (78.53).
Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Account receivable can be measured by Days Sales Outstanding.
Horizon Pharma PLC's Days Sales Outstanding for the fiscal year that ended in Dec. 2015 is calculated as
Horizon Pharma PLC's Days Sales Outstanding for the quarter that ended in Dec. 2015 is calculated as:
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Horizon Pharma PLC Annual Data
Horizon Pharma PLC Quarterly Data